Key Takeaways
- • Ares Management expects Q1 2026 revenue growth of 29.2% year-over-year, a significant deceleration from 40.4% growth in the prior-year quarter, signaling moderating expansion amid competitive pressures in alternative asset management.
- • Consensus estimates project diluted earnings per share of $1.43, representing 31.2% growth from $1.09 in Q1 2025, while full-year EPS is forecast to grow 24.42% from $6.06 to $7.54 per share.
- • Total assets under management are estimated at $647.9 billion (up 4.1% sequentially), with fee-earning AUM projected at $400.8 billion, reflecting continued capital deployment momentum despite recent market sentiment challenges.
- • Ares has a history of missing revenue and EPS estimates over the past two years, creating headwinds into this earnings report; the stock is trading at $111.84 versus a consensus analyst price target of $141.71.
- • Record fundraising and deployment activity in Q1 demonstrate resilience in capital raising, though opportunistic strategies posted a gross loss of 0.2% (with 11.7% gross returns over the trailing twelve months), signaling selective performance challenges in volatile market conditions.
Summary
Ares Management (NYSE: ARES) is positioned to report Q1 2026 earnings with mixed expectations of continued growth tempered by a noticeable deceleration in revenue expansion. The consensus outlook calls for revenue growth of 29.2% year-over-year, a substantial pullback from the 40.4% increase recorded in the same quarter last year, reflecting normalization after a period of elevated capital markets activity and investor risk appetite in alternative assets.
Earnings momentum remains constructive, with analysts projecting diluted EPS of $1.43, up 31.2% from $1.09 in Q1 2025. Full-year earnings expectations have been refined to $7.54 per share, representing 24.42% growth from the prior-year $6.06 figure. Total AUM is expected to reach $647.9 billion (a 4.1% sequential increase), while fee-earning AUM is estimated at $400.8 billion, also up 4.1% from the prior quarter. These metrics underscore sustained capital deployment and fundraising, with sources highlighting record fundraising and robust deployment activity as key operational highlights.
However, Ares enters this earnings event with a credibility deficit. The firm has materially missed both revenue and earnings estimates multiple times over the past two years, creating investor skepticism. In the most recent quarter, the company reported revenues of $1.52 billion, up 23.4% year-over-year—a significant miss against consensus expectations. Within specific strategy segments, opportunistic strategies generated a gross loss of 0.2% in Q1, though the trailing twelve-month gross return for this segment remained positive at 11.7%, suggesting the weakness is concentrated in recent market volatility rather than structural deterioration.
Peer performance provides additional context: Blackstone reported Q1 revenue growth of 24.2%, beating estimates by 1.4%, while Artisan Partners posted 9.3% growth in line with consensus. Both peers experienced post-earnings declines, with Blackstone down 6.2% and Artisan Partners down 3.1%, signaling that strong results in the alternatives sector are not automatically rewarded by equity markets. Ares stock has appreciated 2.5% over the past month, outperforming some peers but well below the 9.1% average gain across the capital markets segment. The stock currently trades at $111.84, roughly 21% below the consensus analyst price target of $141.71, reflecting persistent valuation skepticism despite expectations for continued earnings growth.
Earnings momentum remains constructive, with analysts projecting diluted EPS of $1.43, up 31.2% from $1.09 in Q1 2025. Full-year earnings expectations have been refined to $7.54 per share, representing 24.42% growth from the prior-year $6.06 figure. Total AUM is expected to reach $647.9 billion (a 4.1% sequential increase), while fee-earning AUM is estimated at $400.8 billion, also up 4.1% from the prior quarter. These metrics underscore sustained capital deployment and fundraising, with sources highlighting record fundraising and robust deployment activity as key operational highlights.
However, Ares enters this earnings event with a credibility deficit. The firm has materially missed both revenue and earnings estimates multiple times over the past two years, creating investor skepticism. In the most recent quarter, the company reported revenues of $1.52 billion, up 23.4% year-over-year—a significant miss against consensus expectations. Within specific strategy segments, opportunistic strategies generated a gross loss of 0.2% in Q1, though the trailing twelve-month gross return for this segment remained positive at 11.7%, suggesting the weakness is concentrated in recent market volatility rather than structural deterioration.
Peer performance provides additional context: Blackstone reported Q1 revenue growth of 24.2%, beating estimates by 1.4%, while Artisan Partners posted 9.3% growth in line with consensus. Both peers experienced post-earnings declines, with Blackstone down 6.2% and Artisan Partners down 3.1%, signaling that strong results in the alternatives sector are not automatically rewarded by equity markets. Ares stock has appreciated 2.5% over the past month, outperforming some peers but well below the 9.1% average gain across the capital markets segment. The stock currently trades at $111.84, roughly 21% below the consensus analyst price target of $141.71, reflecting persistent valuation skepticism despite expectations for continued earnings growth.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.